Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without Docetaxel (English)
- New search for: Harshman, Lauren C.
- New search for: Chen, Yu-Hui
- New search for: Liu, Glenn
- New search for: Harshman, Lauren C.
- New search for: Chen, Yu-Hui
- New search for: Liu, Glenn
In:
Journal of clinical oncology
;
36
, 4
;
376-382
;
2018
-
ISSN:
- Article (Journal) / Print
-
Title:Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without Docetaxel
-
Contributors:
-
Published in:Journal of clinical oncology ; 36, 4 ; 376-382
-
Publisher:
- New search for: American Society of Clinical Oncology
-
Publication date:2018-01-01
-
Size:7 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.994
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.994 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 36, Issue 4
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 305
-
Soaring Cost of Cancer Treatment: Moving Beyond Sticker ShockGross, Cary P. / Gluck, Abbe R. et al. | 2018
- 308
-
What Is the Role of Symptom Management and Patient-Reported Outcomes in Adherence to Aromatase Inhibitors?Rocque, Gabrielle et al. | 2018
- 310
-
MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary MyelofibrosisGuglielmelli, Paola / Lasho, Terra L. / Rotunno, Giada et al. | 2018
- 319
-
Trajectories of Injectable Cancer Drug Costs After Launch in the United StatesGordon, Noa / Stemmer, Salomon M. / Greenberg, Dan et al. | 2018
- 326
-
Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202Henry, N. Lynn / Unger, Joseph M. / Schott, Anne F. et al. | 2018
- 333
-
Sequencing of Postoperative Radiotherapy and Chemotherapy for Locally Advanced or Incompletely Resected Non-Small-Cell Lung CancerFrancis, Samual / Orton, Andrew / Stoddard, Greg et al. | 2018
- 342
-
Phase II Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Cisplatin-Based ChemotherapyZucali, Paolo Andrea / De Pas, Tommaso / Palmieri, Giovannella et al. | 2018
- 350
-
Results of a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Trifluridine/Tipiracil (TAS-102) Monotherapy in Asian Patients With Previously Treated Metastatic Colorectal Cancer: The TERRA StudyXu, Jianming / Kim, Tae Won / Shen, Lin et al. | 2018
- 359
-
HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal AdenocarcinomaHingorani, Sunil R. / Zheng, Lei / Bullock, Andrea J. et al. | 2018
- 367
-
Highly Accurate Identification of Cystic Precursor Lesions of Pancreatic Cancer Through Targeted Mass Spectrometry: A Phase IIc Diagnostic StudyJabbar, Karoina S. / Arike, Liisa / Verbeke, Caroline S. et al. | 2018
- 376
-
Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without DocetaxelHarshman, Lauren C. / Chen, Yu-Hui / Liu, Glenn et al. | 2018
- 383
-
Overall Survival in Patients With Advanced Melanoma Who Received Nivolumab Versus Investigator's Choice Chemotherapy in CheckMate 037: A Randomized, Controlled, Open-Label Phase III TrialLarkin, James / Minor, David / D Angelo, Sandra et al. | 2018
- 391
-
Nivolumab Plus Ipilimumab in Patients With Advanced Melanoma: Updated Survival, Response, Safety Data in a Phase I Dose-Escalation StudyCallahan, Margaret K. / Kluger, Harriet / Postow, Michael A. et al. | 2018
- 399
-
Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline UpdateWong, Sandra L. / Faries, Mark B. / Kennedy, Erin B. et al. | 2018
- 414
-
Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017Giri, Veda N. / Knudsen, Karen E. / Kelly, William K. et al. | 2018
- 425
-
A Pathologic Fascination With HumanityGilligan, Timothy et al. | 2018
- 427
-
Additional Recommendations for ALK Gene-Rearranged Non-Small-Cell Lung Cancer to the Recently Updated American Society of Clinical Oncology Guideline for Stage IV Non-Small-Cell Lung CancerVan Hoef, Marlies E. H. M. et al. | 2018
- 427
-
Reply to M.E.H.M. Van HoefHanna, Nasser / Temin, Sarah / Oliver, Thomas K. et al. | 2018
- 428
-
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy in Early-Stage Invasive Breast CancerBlum, Joanne L. / Robert, Nicholas / Andersen, Jay et al. | 2018
- 429
-
Interpretation of the Results of the MINDACT Study and Consequent Recommendations in the Updated ASCO Clinical Practice GuidelineLange, Stefan / Scheibler, Fueloep / Fleer, Daniel et al. | 2018
- 430
-
Reply to J.L. Blum et al and S. Lange et alKrop, Ian / Ismaila, Nofisat / Barlow, William et al. | 2018